We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.29B
AUM Growth
-$106M
Cap. Flow
-$95.5M
Cap. Flow %
-7.43%
Top 10 Hldgs %
37.38%
Holding
190
New
24
Increased
27
Reduced
34
Closed
33

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$30.9M
2
SN icon
SharkNinja
SN
+$23.8M
3
TGTX icon
TG Therapeutics
TGTX
+$18.8M
4
VYX icon
NCR Voyix
VYX
+$16.6M
5
XHR
Xenia Hotels & Resorts
XHR
+$16.4M

Top Sells

Rank Stock Value
1
CNDA
Concord Acquisition Corp II
CNDA
+$25.4M
2
HES
Hess
HES
+$18.8M
3
ATVI
Activision Blizzard
ATVI
+$17.3M
4
ENVA icon
Enova International
ENVA
+$13M
5
BWA icon
BorgWarner
BWA
+$12.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.33%
2 Consumer Discretionary 14.78%
3 Financials 12.97%
4 Energy 5.16%
5 Materials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OHAA
76
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$2.41M 0.19%
231,500
– –
FENC icon
77
Fennec Pharmaceuticals
FENC
$365M
$2.25M 0.18%
300,000
– –
CVNA icon
78
Carvana
CVNA
$76.4B
$2.1M 0.16%
+250,000
New +$2.15M
LKFT
79
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.71B
$2M 0.16%
58,000
– –
ATRA icon
80
Atara Biotherapeutics
ATRA
$76.9M
$1.78M 0.14%
48,000
+8,000
+20% +$356K
ALNY icon
81
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
$1.77M 0.14%
+10,000
New +$1.91M
NUVB icon
82
Nuvation Bio
NUVB
$2.22B
$1.67M 0.13%
1,249,473
-325,527
-21% -$542K
HLVX
83
DELISTED
HilleVax
HLVX
$1.63M 0.13%
+121,200
New +$1.71M
MRNA icon
84
PUT
Moderna
MRNA
$22.5B
$1.55M 0.12%
15,000
-45,000
-75% -$5.02M
IMTXW
85
DELISTED
Immatics N.V. Warrants
IMTXW
$1.49M 0.12%
420,000
– –
MDGL icon
86
PUT
Madrigal Pharmaceuticals
MDGL
$11.9B
$1.46M 0.11%
10,000
-25,000
-71% -$4.71M
GCTS
87
GCT Semiconductor Holding
GCTS
$206M
$1.45M 0.11%
134,938
-265,062
-66% -$2.79M
GOSS icon
88
Gossamer Bio
GOSS
$86.9M
$1.44M 0.11%
+1,726,139
New +$1.99M
KARO icon
89
Karooooo
KARO
$2.04B
$1.27M 0.1%
64,000
– –
XPER icon
90
Xperi
XPER
$378M
$1.2M 0.09%
122,000
-255,200
-68% -$3.02M
IOVA icon
91
CALL
Iovance Biotherapeutics
IOVA
$1.94B
$1.14M 0.09%
+250,000
New +$1.63M
OMGA
92
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1.09M 0.09%
508,242
+33,242
+7% +$133K
MODD icon
93
Modular Medical
MODD
$10.9M
$1.09M 0.08%
31,299
– –
CRESW
94
DELISTED
Cresud SACIF y A. Warrant
CRESW
$854K 0.07%
1,945,318
-232,025
-11% -$116K
PDLB icon
95
Ponce Financial Group
PDLB
$495M
$830K 0.06%
106,137
– –
EIGR
96
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$808K 0.06%
88,333
-36,667
-29% -$737K
VCSA
97
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$692K 0.05%
75,000
+34,706
+86% +$422K
CYPH
98
Cypherpunk Technologies Inc
CYPH
$78M
$676K 0.05%
490,000
+185,001
+61% +$430K
IRS.WS
99
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
$653K 0.05%
1,628,261
+29,186
+2% +$13.4K
ZYME icon
100
Zymeworks
ZYME
$1.73B
$411K 0.03%
64,900
– –
2 3
4
5 6

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, 683 Capital Management held 190 positions worth $1.29B, down 7.6% from $1.39B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

683 Capital Management withdrew a net $95.5M in Q3 2023, closing 33 positions and reducing 34 holdings. Its most notable exit was Concord Acquisition Corp II, an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in GE HealthCare worth $28.9M.

  • 683 Capital Management's largest Q3 2023 buy was GE HealthCare: 425,000 shares worth $28.9M.
  • 683 Capital Management added most to Xenia Hotels & Resorts in Q3 2023, an estimated $16.4M increase.
  • 683 Capital Management's biggest Q3 2023 reduction was Hess, cutting an estimated $18.8M.
  • 683 Capital Management fully exited Concord Acquisition Corp II in Q3 2023, selling an estimated $25.4M.
  • 683 Capital Management's ten largest holdings make up 37% of its $1.29B portfolio in Q3 2023.
  • 683 Capital Management opened 24 new positions and closed 33 in Q3 2023.
  • 683 Capital Management's portfolio value fell 7.6% quarter-over-quarter to $1.29B.

Based on 683 Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.